Year: 2025

Ascom, Dräger, and B. Braun Launch Silent ICU Solution, a Milestone in Patient-Centric Critical Care

Written by Customer Service on October 28, 2025. Posted in Public Companies.

Baar, Switzerland, 28 October 2025 Ascom, in partnership with Dräger and B. Braun, announces the launch of the Silent ICU solution, introduced at the ESICM LIVES 2025 Congress in Munich. This is a major milestone in critical care innovation and marks a new era in healing environment, patient safety, and workflow efficiency for intensive care units (ICUs). The Silent ICU solution is based on full delegation of alarms from the medical devices to the distributed alarm system. The Silent ICU solution is part of the SASICU (Smart and Silent ICU) research program, supported by the Innovative Health Initiative (IHI) under the European Union’s Horizon Europe program. Transforming the ICU Experience The Silent ICU solution seamlessly integrates advanced medical devices and alarm management systems from leading manufacturers and helps provide a...

Banijay Group acquires majority stake in Tipico Group

Written by Customer Service on October 28, 2025. Posted in Mergers And Acquisitions.

Press Release Paris, October 28, 2025 Banijay Group reinforces leadership in sports betting and online gaming with the acquisition of a majority stake in Tipico GroupBanijay Gaming to double in revenue and free cash flow with the combination of Betclic and Tipico under one roofBanijay Group, the Entertainment powerhouse, has signed a binding agreement with CVC and Tipico’s founders to combine Betclic and Tipico groups, becoming the majority shareholder of the combined entity, and creating a European champion in sports betting and online gaming. Banijay Group will buy the major stake of CVC in Tipico in cash, and all shareholders of Betclic and Tipico, including the respective founders, will become shareholders of the combined entity.With the addition of Tipico Group, leader...

Novartis delivers solid sales and core operating income growth with strong pipeline progress in Q3; reaffirms FY 2025 guidance

Written by Customer Service on October 28, 2025. Posted in Earnings Releases And Operating Results.

Ad hoc announcement pursuant to Art. 53 LRQ3 net sales grew +7% (cc1, +8% USD) and core operating income1 grew +7% (cc, +6% USD)Sales growth was driven by continued strong execution on priority brands including Kisqali (+68% cc), Kesimpta (+44% cc), Pluvicto (+45% cc) and Scemblix (+95% cc) Core operating income margin1 was stable (cc) at 39.3% despite increasing generic impactQ3 operating income grew +27% (cc, +24% USD); net income rose +25% (cc, +23% USD) Q3 core EPS1 grew +10% (cc, +9% USD) to USD 2.25 Q3 free cash flow1 was USD 6.2 billion (+4% USD) driven by higher net cash flows from operating activities Strong nine months performance with net sales up +11% (cc, +11% USD) and core operating income up +18% (cc, +16% USD) Q3 selected innovation milestones:Rhapsido FDA approval as the only oral, targeted BTK inhibitor for...

BW ENERGY: THIRD QUARTER RESULTS 2025

Written by Customer Service on October 28, 2025. Posted in Earnings Releases And Operating Results.

BW ENERGY THIRD QUARTER RESULTS 2025 BW Energy delivered continued strong operational performance in the third quarter of 2025, with high production uptime, efficient execution of the annual Dussafu maintenance program and competitive cost levels. The Maromba development and the Golfinho Boost project progressed to plan with key financing milestones completed, and the Kharas-1A appraisal well on the Kudu field offshore Namibia was successfully spudded towards the end of the period. Backed by strong cash generation and a resilient financial structure, BW Energy is well positioned to deliver industry-leading organic growth and create long-term shareholder value. HIGHLIGHTS (Numbers in parenthesis refer to Q3 2024) Strong operational performance Q3 2025 net production of 2.4 (2.4) million barrels (mmbbls), equal to 26.3 (25.6) kbopd ...

Amundi: Third quarter and Nine-month 2025 results

Written by Customer Service on October 28, 2025. Posted in Earnings Releases And Operating Results.

Third quarter and Nine-month 2025 results Pre-tax income1 up +4% Q3/Q3, driven by management fees and technologySustained inflows over nine months and in Q3 Assets under management2 at a new record high of €2,317bn Net inflows +€67bn over nine months, of which +€15bn in Q3+€57bn in medium-to-long-term assets3 (MLT) over nine months Contribution from all major client segments and regions Growth in pre-tax income Third quarter: adjusted pre-tax income1 €445m, growth of +4% Q3/Q34driven by revenue growth (+5%) and cost control5Adjusted net income1 €340m Confirmed successes on the strategic pillars Strong contribution from strategic priorities6Third-party distribution: inflows +€21bn, mainly in MLT assets Asia +€29bn, including +€19bn in JVs7 and +€10bn in direct distribution,...

Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025

Written by Customer Service on October 28, 2025. Posted in Public Companies.

Dubai, UAE / Beijing, China, Oct. 27, 2025 (GLOBE NEWSWIRE) — Qualigen Therapeutics Inc. (NASDAQ: QLGN) (“Qualigen”, “QLGN” or the “Company”), a publicly-traded technology company majority owned by Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future” or “FF”), today announced that it will rebrand as AIxCrypto following its stockholder meeting on November 12, 2025. AIxCrypto’s Strategic Roadmap QLGN (soon to be AIxCrypto) has launched its new Web3 and crypto asset business initiatives. Following its targeted rebranding on November 12, the Company will launch the public beta of its BesTrade DeAI Agent by the end of November and release its EAI RWA Utility Token Whitepaper. By the end of 2025, AIxCrypto aims to achieve three major milestones:Expand the C10 Treasury to $50 Million AUMStrengthen its role as...

UPDATE – Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey

Written by Customer Service on October 28, 2025. Posted in Public Companies.

Expanded 10-plus-year collaboration will leverage Medidata Experiences with the goal of streamlining clinical processes and data, enhancing patient care NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) — Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced an extension of their collaboration with Sanofi in clinical research. As part of this extension Sanofi will use the Medidata Patient, Data, and Study Experiences, building on the organizations’ vision to boost innovation in studies, speed new therapies to market, and promote health outcomes for people globally. The Medidata Experiences address the fragmented, standalone tools of the life sciences industry by offering AI-embedded, platform-based solutions across clinical workflows, unifying trial processes,...

HNI Corporation Announces Extension of Exchange Offer

Written by Customer Service on October 28, 2025. Posted in Mergers And Acquisitions.

MUSCATINE, Iowa, Oct. 27, 2025 (GLOBE NEWSWIRE) — HNI Corporation (NYSE: HNI; “HNI” or “the Corporation”) announced a definitive agreement to acquire Steelcase, Inc. (NYSE: SCS; “Steelcase”) in a cash and stock transaction (the “Acquisition”). In connection with the Acquisition, HNI previously announced the commencement of an offer to exchange any and all outstanding 5.125% Notes due 2029 (the “Existing Steelcase Notes”), as issued by Steelcase, for up to $450,000,000 aggregate principal amount of new notes to be issued by HNI (the “New HNI Notes”). HNI today announced that it has extended the expiration date of its previously announced (A) offer to exchange (the “Exchange Offer”) any and all outstanding Existing Steelcase Notes for New HNI Notes and (B) related solicitation of consents (the “Consent Solicitation”) from the Eligible...

Pulse Seismic Inc. Reports Q3 2025 Financial Results and Declares Regular Quarterly Dividends

Written by Customer Service on October 28, 2025. Posted in Dividend Reports And Estimates.

CALGARY, Alberta, Oct. 27, 2025 (GLOBE NEWSWIRE) — Pulse Seismic Inc. (TSX:PSD) (OTCQX:PLSDF) (“Pulse” or the “Company”) is pleased to report its financial and operating results for the three and nine months ended September 30, 2025. The unaudited condensed consolidated interim financial statements, accompanying notes and MD&A are being filed on SEDAR+ (www.sedarplus.ca) and will be available on Pulse’s website at www.pulseseismic.com. Today, Pulse’s Board of Directors declared a regular quarterly dividend of $0.0175 per common share. The total dividend declared will be approximately $888,000 based on Pulse’s 50,755,057 common shares outstanding as of October 27, 2025, to be paid on November 20, 2025, to shareholders of record on November 13, 2025. This dividend is designated as an eligible dividend for Canadian income tax...

H2O America Announces Third Quarter 2025 Financial Results

Written by Customer Service on October 27, 2025. Posted in Earnings Releases And Operating Results.

Third quarter 2025 reported diluted EPS of $1.27 and adjusted diluted EPS (non-GAAP)1 of $1.27, an 8% increase in adjusted diluted EPS over the prior year 2025 year-to-date reported diluted EPS of $2.48 and adjusted diluted EPS (non-GAAP)1 of $2.53, a 14% increase in adjusted diluted EPS over the prior year 2025 adjusted diluted EPS guidance narrowed to $2.95 to $3.001, the top half of the original range. No change to the long-term diluted EPS growth target Quadvest approval process underway, active connections up 11.5%, or 5,400 connections, between December 31, 2024 and September 30, 2025 Declared $0.42 cash dividend per share of common stockSAN JOSE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) — H2O America (NASDAQ: HTO) today reported financial results for the third quarter of 2025. “This quarter’s performance reflects our team’s...

Year: 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals